Islet rejection in perforin-deficient mice: The role of perforin and fas

Transplantation

Volumn 63, Issue 7, 1997, Pages 951-957

  Ahmed, Khaja R ^a   Guo, Taylor B ^a   Gaal, Karl K ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; GLUCOSE; GRANZYME B; PERFORIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEDIATED CYTOTOXICITY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; EFFECTOR CELL; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD95; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; PORE FORMING CYTOTOXIC PROTEINS;

EID: 0030898567     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704150-00008     Document Type: Article

References (41)

1. Lowry RP, Gurley KE, Forbes RD. Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection. Transplantation 1983; 36: 391.
2. Bradley JA, Mason DW, Morris PJ. Evidence that rat renal allografts are rejected by cytotoxic T cells and not by nonspecific effectors. Transplantation 1985; 39: 169.
3. Steinmuller D. Which T cells mediate allograft rejection? Transplantation 1985; 40: 229.
4. Hall BM. Cells mediating allograft rejection [published erratum appears in Transplantation 1991; 52: 936]. Transplantation 1991; 51: 1141.
5. Kägi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528.
6. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 1994; 370: 650.
7. Walsh CM, Matloubian M, Liu C-C, et al. Immune function in mice lacking the perform gene. Proc Natl Acad Sci USA 1994; 91: 10854.
8. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274.
9. Kägi D, Ledermann B, Bürki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994; 369: 31.
10. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
11. Clément M-V, Legros-Maïda S, Israël-Biet D, et al. Perform and granzyme B expression is associated with severe acute rejection: evidence for in situ localization in alveolar lymphocytes of lung-transplanted patients. Transplantation 1994; 57: 322.
12. Schulz M, Schuurman H-J, Joergensen J, et al. Acute rejection of vascular heart allographs by perforin-deficient mice. Eur J Immunol 1995; 25: 474.
13. Walsh CM, Hayashi F, Saffran DC, Ju S-T, Berke G, Clark WR. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J Immunol 1996; 156: 1436.
14. + T-lymphocyte-deficient recipients. Transplant Proc 1993; 25: 961.
15. 2 alloantibody. Transplant Proc 1994; 26: 749.
16. Liu C-C, Walsh CM, Eto N, Clark WR, Young JD. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. J Immunol 1995; 155: 602.
17. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
18. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177: 195.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
20. Lowrey DM, Aebischer T, Olsen K, et al. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci USA 1989; 86: 247.
21. Lobe CG, Upton C, Duggan B, et al. Organization of two genes encoding cytotoxic T lymphocyte-specific serine proteases CCPI and CCPII. Biochemistry 1988; 27: 6941.
22. Mintz B, Silvers WK. Histocompatibility antigens on melanoblasts and hair follicle cells. Transplantation 1970; 9: 497.
23. Sutton R, Gray DW, McShane P, Dallman MJ, Morris PJ. The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat. J Exp Med 1989; 170: 751.
24. Lu X, Ledermann B, Borel JF. Survival of islet grafts in perforin-deficient mice. Transplant Proc 1995; 27: 3262.
25. Chen RH, Bushell A, Fuggle SV, Wood KJ, Morris PJ. Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibody. Transplantation 1996; 61: 625.
26. Rukavina D, Balen-Marunic S, Rubesa G, Orlic P, Vujaklija K, Podack ER. Perforin expression in peripheral blood lymphocytes in rejecting and tolerant kidney transplant recipients. Transplantation 1996; 61: 285.
27. Pearson TC, Alexander DZ, Hendrix R, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model: evidence for hematopoietic chimerism. Transplantation 1996; 61: 997.
28. 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996; 49: 1297.
29. Watanabe D, Suda T, Hashimoto H, Nagata S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J 1995; 14: 12.
30. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314.
31. Ozdemirli M, El-Khatib M, Foote LC, et al. Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses. Eur J Immunol 1996; 26: 415.
32. French LE, Hahne M, Viard I, et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996; 133: 335.
33. Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69: 415.
34. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 1994; 84: 2622.
35. Fukuo K, Hata S, Suhara T, et al. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 1996; 27: 823.
36. + cytotoxic T lymphocyte clones. Eur J Immunol 1995; 25: 3381.
37. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity: an immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60: 221.
38. Krammer PH, Dhein J, Walczak H, et al. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994; 142: 175.
39. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566.
40. Steinmuller D, Snider ME, Noble RL, Waldschmidt TJ. Dissociation of tissue destruction induced by cytolytic T cells in vivo and cytotoxicity as measured in vitro. Transplantation 1990; 50: 663.
41. Carter LL, Dutton RW. Relative perform- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol 1995; 155: 1028.